Biogen Inc (BIIB)

08:29 AM

Dimensional Fund Advisors LP Reduces Holdings in Biogen Inc. $BIIB - MarketBeat

08:29 AM

08:27 AM

Quantbot Technologies LP Grows Position in Biogen Inc. $BIIB - MarketBeat

08:27 AM

08:27 AM

Level Four Advisory Services LLC Buys 8,685 Shares of Biogen Inc. $BIIB - MarketBeat

08:27 AM

08:25 AM

Biogen Inc. $BIIB Shares Sold by Northern Trust Corp - MarketBeat

08:25 AM

08:25 AM

Korea Investment CORP Raises Stake in Biogen Inc. $BIIB - MarketBeat

08:25 AM

06:11 AM

Biogen Dips 0.26% as $0.19B Volume Ranks 491st in Market Activity Amid Global Smart Shelves Market Surge - AInvest

06:11 AM

01:20 AM

Biogen wins approval of postpartum depression drug Zurzuvae in UK - Seeking Alpha

01:20 AM

12:42 PM

UK Regulator Approves Biogen’s Drug For Treating Postnatal Depression - Stocktwits

12:42 PM

06:17 AM

Biogen Partnership and Zorevunersen Data Could Be a Game Changer for Stoke Therapeutics (STOK) - simplywall.st

06:17 AM

05:07 AM

Price T Rowe Associates Inc. MD Sells 782,524 Shares of Biogen Inc. $BIIB - MarketBeat

05:07 AM

03:56 AM

Biogen Inc. $BIIB Shares Bought by HighTower Advisors LLC - MarketBeat

03:56 AM

Aug 26, 2025

Is Biogen Inc. trending in predictive chart modelsMarket Activity Recap & Real-Time Volume Analysis - Newser

Aug 26, 2025

Aug 26, 2025

Erste Asset Management GmbH Sells 8,360 Shares of Biogen Inc. $BIIB - MarketBeat

Aug 26, 2025

Aug 26, 2025

Candriam S.C.A. Trims Stock Position in Biogen Inc. $BIIB - MarketBeat

Aug 26, 2025

Aug 26, 2025

T. Rowe Price Investment Management Inc. Sells 439,496 Shares of Biogen Inc. $BIIB - MarketBeat

Aug 26, 2025

Aug 26, 2025

Can Biogen Inc. rally from current levelsMarket Activity Summary & Daily Technical Stock Forecast Reports - Newser

Aug 26, 2025

Aug 26, 2025

Can machine learning forecast Biogen Inc. recoveryQuarterly Portfolio Summary & Fast Moving Stock Watchlists - Newser

Aug 26, 2025

Aug 26, 2025

Groupama Asset Managment Sells 1,940 Shares of Biogen Inc. $BIIB - MarketBeat

Aug 26, 2025

Aug 26, 2025

How to forecast Biogen Inc. trends using time seriesEarnings Beat & Accurate Technical Buy Alerts - Newser

Aug 26, 2025

Aug 26, 2025

Fuller & Thaler Asset Management Inc. Acquires 1,880 Shares of Biogen Inc. $BIIB - MarketBeat

Aug 26, 2025

Aug 26, 2025

Does Biogen Inc. show high probability of reboundTrade Entry Summary & Verified Short-Term Trading Plans - Newser

Aug 26, 2025

Aug 26, 2025

Stock Analysis | Biogen OutlookMixed Signals Amid Strong Fundamentals and Inconsistent Analyst Ratings - AInvest

Aug 26, 2025

Aug 26, 2025

Jump Financial LLC Lowers Holdings in Biogen Inc. $BIIB - MarketBeat

Aug 26, 2025

Aug 26, 2025

Ethic Inc. Has $1.04 Million Stock Position in Biogen Inc. $BIIB - MarketBeat

Aug 26, 2025

Aug 26, 2025

Norinchukin Bank The Boosts Stake in Biogen Inc. $BIIB - MarketBeat

Aug 26, 2025

Aug 26, 2025

Is Biogen’s Recent Eisai Partnership a Turning Point for Its 2025 Stock Valuation? - simplywall.st

Aug 26, 2025

Aug 26, 2025

Biogen Inc. $BIIB Shares Sold by AlphaQuest LLC - MarketBeat

Aug 26, 2025

Aug 26, 2025

Biogen shares rise 1.20% premarket after positive clinical data presentations for zorevunersen and LEQEMBI® launch in Europe. - AInvest

Aug 26, 2025

Aug 26, 2025

Banco Bilbao Vizcaya Argentaria S.A. Buys 2,231 Shares of Biogen Inc. $BIIB - MarketBeat

Aug 26, 2025

Aug 26, 2025

Biogen Inc. $BIIB Shares Sold by Stoneridge Investment Partners LLC - MarketBeat

Aug 26, 2025

Aug 25, 2025

Analyzing drawdowns of Biogen Inc. with statistical toolsEntry Point & Community Verified Trade Signals - Newser

Aug 25, 2025

Aug 25, 2025

How to use a screener to detect Biogen Inc. breakoutsQuarterly Trade Report & Low Risk Entry Point Guides - Newser

Aug 25, 2025

Aug 25, 2025

Breakthrough: 3-Year Study Shows Biogen's Drug May Modify Dravet Syndrome Disease Course - Stock Titan

Aug 25, 2025

Aug 25, 2025

Credit Agricole S A Grows Stock Holdings in Biogen Inc. $BIIB - MarketBeat

Aug 25, 2025

Aug 25, 2025

Biogen Inc. (BIIB) Stock Analysis: Exploring The 21.63% Potential Upside - DirectorsTalk Interviews

Aug 25, 2025

Aug 25, 2025

Eisai and Biogen Launch LEQEMBI® in Austria and Germany as First Alzheimer’s Disease Therapy Approved in Europe Targeting Amyloid Beta - Quiver Quantitative

Aug 25, 2025

Aug 25, 2025

Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI® (lecanemab) - Biogen

Aug 25, 2025

Aug 25, 2025

Biogen says Austria and Germany to become the first markets in the European Union to launch Leqembi (lecanemab) - MarketScreener

Aug 25, 2025

Aug 25, 2025

First EU Launch: Breakthrough Alzheimer's Drug LEQEMBI Shows 31% Disease Slowdown in Early-Stage Patients - Stock Titan

Aug 25, 2025

Aug 24, 2025

State of New Jersey Common Pension Fund D Sells 3,783 Shares of Biogen Inc. $BIIB - MarketBeat

Aug 24, 2025

Aug 23, 2025

Biogen (BIIB): Reassessing Valuation After Recent Share Price Recovery - simplywall.st

Aug 23, 2025

Aug 23, 2025

Tocqueville Asset Management L.P. Sells 17,160 Shares of Biogen Inc. $BIIB - MarketBeat

Aug 23, 2025

Aug 23, 2025

Biogen Inc. $BIIB Shares Sold by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat

Aug 23, 2025

Aug 22, 2025

Biogen: Analyst Estimates & Ratings - AInvest

Aug 22, 2025

Aug 22, 2025

Biogen’s Phase 3 Study on Felzartamab: A Potential Game-Changer for IgA Nephropathy - TipRanks

Aug 22, 2025

Aug 22, 2025

Biogen’s Innovative Study on Litifilimab Delivery: Market Implications and Study Insights - TipRanks

Aug 22, 2025

Aug 22, 2025

Biogen’s Litifilimab Study: A Potential Game-Changer for Lupus Treatment? - TipRanks

Aug 22, 2025

Aug 22, 2025

Biogen Stock: Analyst Estimates & Ratings - MSN

Aug 22, 2025

Aug 22, 2025

J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffs - Benzinga

Aug 22, 2025

Aug 21, 2025

Biogen’s Promising Phase 3 Trial: Felzartamab for Kidney Transplant Rejection - TipRanks

Aug 21, 2025